Video
Dr. Bratslavsky discusses emerging research in renal cell carcinoma
Author(s):
“There are, indeed, numerous paths that we are trying to tackle from different angles,” says Gennady Bratslavsky, MD.
Video Player is loading.
In this video, Gennady Bratslavsky, MD, discusses key research that will be clinically significant in the renal cell carcinoma space. These ideas are associated with a presentation he gave at the 15th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies. Bratslavsky is a Phillip Capozzi M.D. Endowed Professor of Urology, chair of urology, and director of the prostate cancer program at SUNY Upstate Medical University in Syracuse, New York.
Related Videos
Rebecca A. Campbell, MD, discusses citation rates for men and women in the oncology literature
Study data point to gender disparities in oncology research citations
Nitin Yerram, MD, highlights new resource center for patients with renal cell carcinoma
Betty Wang, MD, recaps 3 key urologic cancer studies from EAU 2025
Darren Feldman, MD, on study of 177Lu-girentuximab plus nivolumab for ccRCC
Francesca Jackson-Spence, MBChB, details the ongoing SAMETA trial in papillary renal cancer
Kate Gessner, MD, on systemic agents vs MDT after kidney cancer progression
Taylor Goodstein, MD, highlights project on staging in larger kidney tumors
Chad Tang, MD: Considerations for SBRT in metastatic RCC
Considering patient-reported outcomes in kidney cancer care, with Nicholas Zaorsky, MD, PhD
Related Content
